FDA Inspection
Inopak LtdInopak Ltd – FDA Inspection, Aug 3, 2023
Record Details
This FDA Inspection record concerns Inopak Ltd, with an inspection on August 3, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 224adfbd-9afe-4994-83d4-6cc6410b606a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1214661
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.22(a)Contract drug products--lack of responsibility
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.22(a)Contract drug products--lack of responsibility
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Inopak Ltd
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 18, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 20, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 11, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Inopak Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.